Skip to main content

Day: February 26, 2026

Bouygues: Very robust 2025 results and free cash flow at a record level

Paris, 26 February 2026 PRESS RELEASE Very robust 2025 results and free cash flow at a record levelGroup sales, as published, stable at €56.9bn, including exchange rate effects of around -€580m in 2025, of which around -€560m in the second half. Significant increase in current operating profit from activities (COPA) to €2,655m (up €120m year-on-year), exceeding the Group’s targets. Net profit attributable to the Group rose to €1,138m (up €80m year-on-year) despite the exceptional income tax surcharge for large companies in France of €69m. Group free cash flow before WCR at an all-time record high of €1,808m and showing growth for the 3rd year in a row. Change in WCR was +€941m year-on-year, representing a cumulative increase of around €3bn over three years. Significant improvement in net debt at end-December 2025 at €4,204m, down €1,862m...

Continue reading

Azerion publishes Interim Unaudited Financial Results Q4 2025 and Preliminary Unaudited Financial Results Full Year 2025

Platform focus yields highest ever quarter revenues and adjusted EBITDA In 2025, Azerion focused on its Platform business, introduced Azerion Intelligence (our multi-cloud and AI platform), refinanced its bonds and executed on efficiencies and cost savings. Our fourth quarter and our full year 2025 results show the consolidated effect of that focus. At the same time, our investments in multi-cloud and AI are already showing promising results and opportunities for growth.                                                                                 Results for the continuing operationsQ4 2025Total Revenue of € 169.5 million (+11%compared to € 153.1 million in Q4 2024) Adjusted EBITDA of € 28.8 million (+13%compared to € 25.4 million in Q4 2024) EBITDA of € 14.2 million (compared to € (3.2) million in Q4 2024)FY 2025Total...

Continue reading

Alm. Brand A/S – Annual Report 2025

Alm. Brand released its preliminary statement of financial results for 2025 on 29th January 2026. Please find attached the Group’s Annual Report for 2025. Contact Please direct any questions regarding this announcement to: Investors and equity analysts:            Head of Investor Relations & ESG      Mads Thinggaard                                Mobile no. +45 2025 5469                 Press:                                                                                       Media Relations ManagerMikkel Luplau SchmidtMobile no. +45 2052 3883AttachmentsAnnual Report 2025 Alm Brand ASAS 12 2026 – Annual Report

Continue reading

WENDEL: 2025 Full-Year Results

   PRESS RELEASE – FEBRUARY 26, 2026 2025 Full-Year Results In 2025, Wendel accelerated the transformation of its business model:€1591 million of proforma FRE generated by Wendel Investment Managers Strengthened operational profile of Wendel Principal InvestmentsStrong progress in the execution of the 2030 strategic roadmap announced in December 2025:€1.65 billion of disposals announced to date More than €5002 million to be returned to shareholders in 2026Fully diluted3 NAV per share of €164.2 as of December 31, 2025 Wendel Investment Managers: strong organic growth in revenues and fundraising in 2025, continued build-out of the platformWendel Investment Managers, Wendel’s third-party asset management platform reached €41.2 billion assets under management as of December 31,2025 and will reach €47 billion AuM upon completion...

Continue reading

Prosafe SE: Fourth-quarter results 2025

This release contains forward-looking statements based on current assumptions and forecasts made by the Group. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the Group and the estimates given here. (Figures in brackets refer to the corresponding period last year1) 26 February 2026 – Prosafe SE reported EBITDA of USD 21.1 million (USD 8.4 million) for the fourth quarter of 2025. All the company’s five vessels generated revenue through-out the quarter, with four units active during the full period and the Safe Boreas arriving in Australia ahead of the expected start of operations in the first quarter of 2026.   Full-year 2025 EBITDA was USD 40.0 million, at the high end of the guided range for the year,...

Continue reading

CMB.TECH ANNOUNCES Q4 2025 RESULTS – EIGHT VLCCS SOLD AT STELLAR PRICES

CMB.TECH ANNOUNCES Q4 2025 RESULTSEIGHT VLCCS SOLD AT STELLAR PRICES ANTWERP, Belgium, 26 February 2026 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) reported its unaudited financial results today for the fourth quarter ended 31 December 2025. HIGHLIGHTS Financial highlights:Profit for the period of USD 90.1 million in Q4 2025. EBITDA for the same period was USD 322 million. CMB.TECH’s contract backlog increased by USD 304 million to USD 3.05 billion with the addition of 5 x 5-year charters for Capesizes and a 3-year contract for a CSOV. Declaration of an interim dividend of USD 0.16 per share. Over the course of Q4 2025 and Q1 2026, the company has fully repaid the bridge loan facility that was originally raised to finance the acquisition of a large stake in Golden...

Continue reading

Bekaert: 2025 Full Year Results

2025 Full year results Resilient results and strong cash flow supported by cost management and restructuring FCF1 of €314m n Proposed dividend of €1.95 n Ongoing €200m share buyback Bekaert delivered a resilient performance in 2025. The year was marked by shifts in global trade policies which created uncertainty and undermined demand. In addition, slower growth in the hydrogen end market required adjustment to bring footprint in line with demand outlook. At the same time, Bekaert has translated robust demand from investments in power and data transmission networks into increased sales and order books. Within these mixed global market dynamics, sales volumes remained flat versus 2024, while pass-through of lower input costs, currency and mix impacts and the strategic exit of lower margin business in Latin America reduced sales. Cost savings...

Continue reading

Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced its attendance and presentations at upcoming investor conferences. Molecular Partners will also issue its full-year 2025 financial report, along with its Annual Report, on March 12, 2026. Details of the events: TD Cowen 46th Annual Health Care ConferenceBoston, MA, March 2-4, 2026Molecular Partners CEO Patrick Amstutz will take part in a fireside chat on Monday, March 2 at 2.30-3.00 pm ET (8.30-9.00 pm CET). Leerink Partners Global Healthcare Conference 2026Miami, FL, March 9-11 March, 2026Molecular Partners CEO Patrick Amstutz will...

Continue reading

dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program

Press Release dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), February 26 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announces that following the completion of its €1.08 billion share buyback program in 2025, the company has cancelled 12,049,441 shares. As a result, the total number of issued shares has been reduced by approximately 4.5%, from 265,676,388 to 253,626,947 shares. For more information, please contact: dsm-firmenich investor relations enquiries:Email: investors@dsm-firmenich.com dsm-firmenich media enquiries:Email: media@dsm-firmenich.com    About dsm-firmenichAs innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances...

Continue reading

Corbion announces strong full-year 2025 results with +26.7% organic Adjusted EBITDA growth, +63.3% EPS growth, and €90.8 million in FCF; announces special dividend

Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, today publishes its results for the year ending 31 December 2025.Key highlights annual results 2025:   Organic sales growth: +2.2% (Q4: +5.4%) Volume/mix: +3.4% (Q4: +8.8%) Price:           -1.2% (Q4: -3.4%) Sales: € 1,267.4 million (Q4: € 310.2 million) Adjusted EBITDA: € 204.3 million   (Q4: € 48.0 million)Adjusted EBITDA organic growth of +26.7%  Operating profit: € 116.5 million, an organic increase of +66.1%  Cash flow from operating activities: € 160.9 million  Free Cash Flow: € 90.8 million  EPS increased +63.3% to €1.29 Proposal to distribute a dividend of €1.00 per share consisting of a regular dividend of € 0.64...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.